Fidelity Disruptive Medicine ETF (FMED)

NASDAQ: FMED · Real-Time Price · USD
22.97
-0.16 (-0.69%)
Aug 7, 2025, 4:00 PM - Market closed
-0.69%
Assets$53.04M
Expense Ratio0.50%
PE Ratio42.27
Shares Out2.22M
Dividend (ttm)$0.11
Dividend Yield0.49%
Ex-Dividend DateDec 20, 2024
Payout Frequencyn/a
Payout Ratio20.70%
Volume8,099
Open23.22
Previous Close23.13
Day's Range22.80 - 23.22
52-Week Low20.69
52-Week High26.79
Beta1.01
Holdings71
Inception DateApr 16, 2020

About FMED

Fund Home Page

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is issued by Fidelity.

Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol FMED
ETF Provider Fidelity

Top 10 Holdings

39.12% of assets
NameSymbolWeight
Boston Scientific CorporationBSX5.61%
Alnylam Pharmaceuticals, Inc.ALNY5.12%
Fidelity Securities Lending Cash Central Fundn/a4.78%
argenx SEARGX3.94%
Veeva Systems Inc.VEEV3.64%
Danaher CorporationDHR3.50%
UCB SAUCB3.23%
Insulet CorporationPODD3.22%
Legend Biotech CorporationLEGN3.12%
Waystar Holding Corp.WAY2.97%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 20, 2024$0.112Dec 24, 2024
Jun 21, 2024$0.001Jun 25, 2024
Full Dividend History

Performance

FMED had a total return of -5.36% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.86%.

News

Exploring Key Tailwinds for Fidelity's Disruptive ETFs

Fidelity Investment's suite of disruptive ETFs are designed to capture growth opportunities arising from groundbreaking innovation and transformative technologies.

Other symbols: FBOTFDCFFDFFFDIFFDTX
4 weeks ago - ETF Trends

First Look At FMED: Poor Performance Merits A Strong Sell Rating

Fidelity Disruptive Medicine ETF invests in innovative healthcare companies, focusing on sectors like robotic surgery, genomics, and advanced diagnostics, aiming to disrupt traditional medical practic...

3 months ago - Seeking Alpha

Why traditional active managers are joining the ETF space

Greg Friedman, head of ETF management and strategy at Fidelity Investments, joins 'Halftime Report' to discuss a spike in ETF flows going to active management, Fidelity's decision to convert mutual fu...

Other symbols: FBOTFDCFFDFFFDIFFDTX
2 years ago - CNBC Television